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In vitro, topographical and biophysical cues arising
from the extracellular matrix (ECM) direct skeletal
stem cell (SSC) commitment and differentiation.
However, the mechanisms by which the SSC-ECM
interface is regulated and the outcome of such inter-
actions on stem cell fate in vivo remain unknown.
Here we demonstrate that conditional deletion of
the membrane-anchored metalloproteinase MT1-
MMP (Mmp14) in mesenchymal progenitors, but
not in committed osteoblasts, redirects SSC fate
decisions from osteogenesis to adipo- and chondro-
genesis. By effecting ECM remodeling, MT1-MMP
regulates stem cell shape, thereby activating a b1-in-
tegrin/RhoGTPase signaling cascade and triggering
the nuclear localization of the transcriptional coacti-
vators YAP and TAZ, which serve to control SSC line-
age commitment. These data identify a critical MT1-
MMP/integrin/YAP/TAZ axis operative in the stem
cell niche that oversees SSC fate determination.
INTRODUCTION
Skeletal stem cells (SSCs; alternatively termed mesenchymal
stem cells) are multipotent precursors that give rise to bone,
fat, and cartilage during embryonic development and play critical
roles in maintaining postnatal homeostasis (Chan et al., 2009;
Me´ndez-Ferrer et al., 2010; Morikawa et al., 2009; Omatsu
et al., 2010; Park et al., 2012; Sacchetti et al., 2007). In vivo,
SSCs reside in specialized vascular or bone-associated niches402 Developmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Inwhere they are recruited into surrounding networks of extracel-
lular matrix (ECM) molecules that are distinguished by their
high content of type I collagen (Morikawa et al., 2009; Nilsson
et al., 1998; Rowe and Weiss, 2009; Tancred et al., 2009; Tang
et al., 2009). In vitro studies have highlighted the importance of
SSC-ECM interactions, as lineage commitment and differentia-
tion are sensitive to changes in matrix rigidity, topology, and
dimensionality (Eyckmans et al., 2011). In these in vitro sce-
narios, SSC differentiation programs are analyzed under condi-
tions in which the progenitor cell acts as a passive responder
to experimental changes in ECM structure (Eyckmans et al.,
2011; Huebsch et al., 2010; Kilian et al., 2010). However, whether
SSCs themselves express an intrinsic ability to remodel their
ECMmicroenvironment in order to direct cell-fate determination
remains unknown.
Of the more than 20 ECM-degrading members of the matrix
metalloproteinase (MMP) gene family, membrane-type 1 MMP
(MT1-MMP; encoded by the gene Mmp14) serves as the domi-
nant pericellular collagenase operative in epithelial and mesen-
chymal cell populations (Rowe and Weiss, 2009). To date,
MT1-MMP further distinguishes itself from all other MMPs as
the only family member whose global deletion in mice results
in early postnatal death (Holmbeck et al., 1999; Rowe andWeiss,
2009; Zhou et al., 2000). However, the multiplicity of organ sys-
tems affected inMmp14-targetedmice—coupled with the broad
tissue distribution of the enzyme—has precluded efforts to iden-
tify the core functions of the proteinase in the in vivo setting
(Rowe and Weiss, 2009). MT1-MMP knockout mice are known
to display defects in bone, cartilage, and white fat depots but,
in each case, altered tissue function has been postulated to arise
primarily as a direct consequence of the impaired ability of oste-
oblasts, chondrocytes, or preadipocytes to remodel the
collagen-rich pericellular milieu in which they are embedded
(Chun et al., 2006; Holmbeck et al., 1999, 2003; Szabova et al.,c.
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tional knockout mice wherein Mmp14 has been inactivated in
SSC populations, we alternatively describe an upstream role
for MT1-MMP in controlling the ability of stem cells to undergo
lineage commitment to bone, fat, or cartilage via a b1-integrin
cascade that controls the transcriptional regulators Yes-
association protein (YAP) and transcriptional coactivator with
PDZ-binding motif (TAZ). These studies identify MT1-MMP as
a cell-intrinsic regulator of the SSC-ECM interactions that control
lineage commitment during early development.
RESULTS
Mesenchymal Progenitor/SSC-Targeted Deletion of
MT1-MMP Elicits Multiple Defects in Mesenchyme-
Derived Tissues
In MT1-MMP/lacZ knockin (MT1-MMP+/lacZ) mice, b-galactosi-
dase activity is localized within tissue sites enriched in mesen-
chymal progenitor and SSCs such as the periosteum, perichon-
drium, calvaria, and bonemarrow (Figures 1A–1D). As predicted,
MT1-MMP is further detected in freshly isolated Sca-1+CD29+/
CD45CD11 bone-marrow-derived SSCs (Tang et al., 2009)
by quantitative RT-PCR, with only background levels registering
in cells isolated from Mmp14/ mice (Figure 1E; Figure S1A
available online). Furthermore, when SSCs are induced to differ-
entiate in vitro, MT1-MMP expression is upregulated during os-
teogenesis, whereas commitment to either the adipogenic or
chondrogenic pathways results in decreasedMT1-MMP expres-
sion (Figure 1F; Figure S1B).
To assess the role of MT1-MMP in SSC commitment, a condi-
tionalMmp14-deleted mouse model was generated by crossing
Mmp14f/f mice with Dermo1-Cre-expressing mice (Figure 1G), a
transgenic line wherein Cre activity is largely confined to mesen-
chymal progenitor cells and SSCs (Day et al., 2005; Liu et al.,
2010). Neonatal Mmp14f/f/Dermo1-Cre mice appear grossly
normal at birth despite confirmation that MT1-MMP has been
deleted in bone-marrow-derived SSCs (Figure S1C). Further,
SSC viability and number are equivalent in Mmp14f/f/Dermo1-
Cre mice and Mmp14f/f mice (i.e., comparable numbers of col-
ony-forming unit fibroblasts [CFU-Fs]; Figure 1H). Nevertheless,
by postnatal days 4–5, defects in growth, both in terms of overall
body size and weight, become evident, with more severe pheno-
typic changes displayed as the mice age (Figure 1I). By 120–
150 days of age, more than 90% of Mmp14f/f/Dermo1-Cre
mice (31 out of 34) die, with nomice surviving beyond 10months.
As Mmp14f/f/Dermo1-Cre mice age, they develop a marked
skeletal phenotype that includes short snouts and dome-shaped
skulls (Figures 1I and1J). Further,membranousossification of the
skull is delayed and suture closure is not observed during the life-
time of the mice (Figure 1J). Cross-sections of the lambdoid su-
ture of Mmp14f/f/Dermo1-Cre mice show delayed ossification
along with thickening of the cartilaginous component relative to
Mmp14f/f mice, in combination with marked decreases in
mRNA levels of osteogenic markers (i.e., Osterix, alkaline phos-
phatase [Alp], and osteocalcin) and increased expression of
chondrogenicmarkers (Sox9,collagen type II, andaggrecan) (Fig-
ures 1K and 1L). Defective osteogenesis is not confined to cranial
tissues, as osteopenia is apparent throughout the skeleton of
adult Mmp14f/f/Dermo1-Cre mice with no apparent changes inDeveosteoclast number (Figures 1M and 1N; Figure S1D). As in the
skull, defects in bone formation are also found in association
with marked thickening of articular cartilage (Figure S1E). Finally,
in addition to the observed changes in bone and cartilage, condi-
tional knockout mice display significant increases in both bone-
marrow adiposity and adipogenic gene expression (i.e., AP2,
Pparg, andCebpa) (Figure 1O). By contrast, adipocytes localized
to dermal fat pads that arise from distinct progenitor cell popula-
tions (Gupta et al., 2012; Tran et al., 2012) fail to generate subcu-
taneous fat (Figure S1F)—a phenotype similar to that described
previously by our group inMmp14/ mice (Chun et al., 2006).
Osteoblast Progenitor Cell-Specific MT1-MMP Ablation
Results in Aberrant Bone Formation with Intact
Chondrogenesis and Adipogenesis
To determine whether the increase in chondrogenesis and adi-
pogenesis observed in Mmp14f/f/Dermo1-Cre mice results
from a primary ossification defect (Karsenty and Ferron, 2012),
Mmp14f/f/Osterix-GFP-Cre mice were generated wherein Cre
expression is confined primarily to the osteoblast progenitor line-
age (Zhou et al., 2010). Mmp14f/f/Osterix-GFP-Cre mice are
viable and fertile, with Mmp14 deletion confirmed in GFP-posi-
tive calvarial cells from newborn mice (Figures S2A and S2B).
Conditional ablation of Mmp14 in osteoblast progenitors results
in a bone phenotype with retarded membranous ossification of
calvarial bones and delayed suture fusion, although milder in
phenotype than that observed in Mmp14f/f/Dermo1-Cre mice
(compare Figure 2A and Figure 1J). Nevertheless, cartilage
deposition in newborn calvaria is comparable between
Mmp14f/f/Osterix-GFP-Cremice andMmp14f/fmice, with no sig-
nificant differences in Sox9, collagen type II, or aggrecan expres-
sion detected in calvarial extracts, despite significant decreases
in Osterix, Alp, and osteocalcin expression (Figures 2B and 2C).
Further, although microcomputed tomography analysis
confirmed a general osteopenic phenotype in Mmp14f/f/Os-
terix-GFP-Cre mice (Figures 2D and 2E), neither adult femur
articular cartilage nor bone-marrow adipocyte populations are
expanded (Figures 2F and 2G; Figure S2C), whereas the ratio
of osteoclast number to bone surface is comparable to that
observed in control littermates (Figure S2D). Hence, the condi-
tional deletion of Mmp14 in committed osteoblast progenitors
decreases ossification without impacting chondrogenesis or
adipogenesis—a phenotype distinct from that observed in
mesenchymal progenitor/stem cell-targeted mice.
MT1-MMP Regulates SSC Commitment and
Differentiation
To determine whether MT1-MMP directs SSC lineage com-
mitment in vitro, SSCs were isolated from Mmp14+/+ or
Mmp14/ mice and cultured under standard, low-density, 2D
conditions in proadipogenic or -osteogenic media. In contrast
to the marked defects observed in vivo, wild-type (WT) and
MT1-MMP/ cells commit to the osteogenic or adipogenic line-
age in comparable fashion as determined by alkaline phospha-
tase or oil red O staining as well as the expression of osteogenic
or adipogenic markers (Figures S3A and S3B). In vivo, however,
SSCs are recruited and differentiate in close association with
a 3D ECM that is rich in type I collagen, a preferred substrate
for MT1-MMP (Lu et al., 2010; Maes et al., 2010; Morikawalopmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Inc. 403
Figure 1. Expression and Genetic Inactivation of MT1-MMP in SSCs
(A) LacZ expression in perichondrium (Y), periosteum (YY), and bone (D), but not cartilage (*), in 7-day-oldMmp14+/LacZ mouse femur. The scale bar represents
1 mm.
(B) LacZ expression in calvaria of a 10-day-old Mmp14+/LacZ mouse. The scale bar represents 500 mm.
(C) LacZ expression in sagittal suture mesenchymal progenitors (upper panel, section from the white boxed region in B) versus LacZ expression in mesenchymal
progenitors and osteoblasts residing on the calvarial surface in 10-day-old Mmp14+/LacZ mice (black boxed region in B is enlarged). The scale bar represents
100 mm.
(legend continued on next page)
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MT1-MMP Regulates SSC Lineage Commitmentet al., 2009). To alternatively assess the impact of MT1-MMP ac-
tivity on cell-fate determination wherein 3D matrix interactions
are operative, SSCs were embedded under low-density condi-
tions in a preformed type I collagen matrix. Unlike the normal
lineage commitment patterns of MT1-MMP/ SSCs cultured
in 2D collagen, null stem cells cultured under osteogenic condi-
tions in 3D collagen hydrogels display a significant decrease in
osteoblast commitment relative to MT1-MMP+/+ cells (Figures
3A and 3B). By contrast, under proadipogenic conditions in 3D
culture, SSCs isolated from Mmp14/ mice display an even
stronger disposition than WT cells to commit to the adipocyte
lineage (Figures 3A and 3B). Defects in MT1-MMP/ SSC line-
age commitment are not observed when cells are cultured atop
(rather than embedded within) the 3D hydrogels (Figures S3C
and S3D). Further, when SSCs are cultured in micromass under
chondrogenic conditions, SSCs isolated from Mmp14/ mice
display a heightened chondrogenic potential relative to WT
SSCs (Figures 3A and 3B). The ability of MT1-MMP to direct line-
age commitment is not confined to SSCs, as calvaria-derived
mesenchymal progenitors harvested from Mmp14/ mice like-
wise fail to undergo normal osteogenesis whereas preferentially
committing to a chondrogenic phenotype in 3D culture (Figures
S3E and S3F). Finally, when MT1-MMP/ SSCs are explanted
into nude mice recipients, osteogenesis is similarly impaired,
whereas adipogenic and chondrogenic potential are enhanced
in vivo (Figures 3C–3F).
MT1-MMP-Dependent ECM Remodeling Controls SSC
Differentiation via b1-Integrin Activation
To determine whether MT1-MMP function during cell-fate spec-
ification is—or is not—dependent on its ECM remodeling activ-
ity, MT1-MMP/ SSCs were transduced with lentiviral vectors
encoding WT or a catalytically inactive MT1-MMP mutant (Shi-
mizu-Hirota et al., 2012), and lineage commitment was assessed
in vitro. Having confirmed equivalent expression of WT and
mutant MT1-MMP by western blot, only WT MT1-MMP expres-
sion elicits SSC-mediated type I collagenolytic activity (Fig-
ure 4A). More importantly, reexpression of WT MT1-MMP, but(D) LacZ expression in a subpopulation of bone-marrow cells in the femur of a 1
(E) Real-time PCRofMmp14 expression in SSCs from 14-day-oldMmp14+/+ andM
t test.
(F) Schematic representation of the commitment of SSCs into three major lineag
(G) Schematic of theMmp14 genomic locus and targeting construct. After homolo
exons 1 and 2, and two LoxP sites were inserted into the introns between exons
(H) CFU-F generation from bone-marrow cells isolated from 4-week-oldMmp14f/f
SEM. Not significant, unpaired t test.
(I) Gross view of a 14-day-old Mmp14f/f/Dermo1-Cre mouse and its control litter
(J) Alizarin red/Alcian blue staining of skulls isolated from 10-day-old Mmp14f/f a
(K) Histology of newbornMmp14f/f andMmp14f/f/Dermo1-Cre skulls across the la
the right). Relative bone and cartilage thickness are shown to the right (n = 5). The
unpaired t test.
(L) Relative mRNA expression of osteogenic and chondrogenic markers in newbo
mice (n = 6). Data are presented as mean ± SEM. **p < 0.01, unpaired t test.
(M) Microcomputed tomography of the proximal femur of 12-week-old Mmp14f/
(N) Bone mineral density (BMD), bone volume/tissue volume (BV/TV), trabecular
measured by microcomputed tomography in 12-week-old Mmp14f/f and Mmp14
unpaired t test.
(O) Histology of femur bone-marrow cavity and relative mRNA expression of adip
Mmp14f/f/Dermo1-Cre mice (n = 6). The scale bar represents 100 mm. Data are p
See also Figure S1.
Devenot the catalytically inactive mutant, in MT1-MMP/ SSCs in-
creases osteogenesis in 3D culture, whereas inhibiting adipo-
genesis and chondrogenesis in a pattern that phenocopies the
behavior of WT SSCs (Figure 4B). Consistent with these results,
using a combination of (1) antibodies specific for type I collagen
degradation fragments and (2) second harmonic generation
(SHG) to visualize intact type I collagen networks in vivo, collage-
nolytic activity is readily detected within fields of collagen fibrils
in Mmp14f/f calvarial bone and sutures (Figure 4C). By contrast,
in Mmp14-targeted mice, collagenolytic activity is reduced to
background levels amid a denser network of type I collagen fi-
brils (Figure 4C).
Cell adhesion to the ECM triggers cell spreading and shape
changes that are required for b1-integrin activation, a critical
step in the SSC differentiation program (Eyckmans et al.,
2011). As assessed by imaging of SSCs from GFP transgenic
mice in 3D culture, MT1-MMP+/+/GFP cells assume a spread,
fibroblast-like, spindle morphology, whereas MT1-MMP//
GFP SSCs, by virtue of their inability to remodel the surrounding
collagen matrix, are confined to more constrained shapes with a
50% decrease in relative cell-surface area (Figure 4D). Likewise,
in GFP-expressing transgenic mouse tissues, MT1-MMP/
mesenchymal progenitors and osteoblasts, as well as fibro-
blast-like cells in the bone-marrow compartment, display smaller
cell bodies with a 2-fold mean decrease in cell-surface area rela-
tive to that found in Mmp14+/+/GFP mice (Figure S4A). As SSC-
collagen interactions are mediated largely by b1-integrins
(Popov et al., 2011), the total versus active levels of b1-integrin
were assessed with conformation-specific antibodies in MT1-
MMP+/+ and MT1-MMP/ SSCs in 3D culture as well as in vivo
(Rantala et al., 2011). Immunostaining of in vitro cultures reveals
that the pools of both total and active b1-integrins are distributed
throughout the cell bodies of MT1-MMP+/+ SSCs, but in MT1-
MMP/ SSCs only low levels of active b1-integrin are detected,
with the bulk of the total b1-integrin content confined to the
perinuclear region (Figure 4E). Consistent with the impaired acti-
vation status of b1-integrins in MT1-MMP/ SSCs, FAK phos-
phorylation at Y397 (P-FAK; a downstream target of activated2-month-old Mmp14+/LacZ mouse. The scale bar represents 100 mm.
mp14/mice (n = 3). Data are presented asmean ± SEM. **p < 0.01, unpaired
es.
gous recombination, the FRT-flanked Neo was inserted into the intron between
1 and 2 and exons 4 and 5.
/Dermo1-Cremice and control littermates (n = 6). Data are presented asmean ±
mate (Mmp14f/f).
nd Mmp14f/f/Dermo1-Cre mice. The scale bar represents 2 mm.
mbdoid suture area (boxed area sectioned and magnified in the two panels to
scale bar represents 100 mm. Data are presented as mean ± SEM. **p < 0.01,
rn (1-day-old) calvarial RNA extracts fromMmp14f/f andMmp14f/f/Dermo1-Cre
f and Mmp14f/f/Dermo1-Cre mice.
thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp)
f/f/Dermo1-Cre mice (n = 10). Data are presented as mean ± SEM. **p < 0.01,
ogenic markers in bone-marrow RNA extracts from 12-week-oldMmp14f/f and
resented as mean ± SEM. **p < 0.01, unpaired t test.
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Figure 2. Osteopenia in Mice with Osteo-
blast Progenitor-Targeted Inactivation of
MT1-MMP
(A) Alizarin red/Alcian blue staining of skulls iso-
lated from 10-day-old Mmp14f/f and Mmp14f/f/
Osterix-GFP-Cre mice. The scale bar represents
2 mm.
(B) Histology of newborn Mmp14f/f and Mmp14f/f/
Osterix-GFP-Cre mice skulls across the lambdoid
suture area (boxed area in A, sectioned). Relative
bone/cartilage thickness is shown to the right (n =
5). The scale bar represents 100 mm. Data are
presented as mean ± SEM. **p < 0.01, unpaired
t test.
(C) Relative mRNA expression of osteogenic and
chondrogenic markers in 1-day-old calvarial RNA
extracts from Mmp14f/f and Mmp14f/f/Dermo1-
Cre mice (n = 6). Data are presented as mean ±
SEM. *p < 0.05, unpaired t test.
(D) Microcomputed tomography of the proximal
femur of 12-week-old Mmp14f/f and Mmp14f/f/
Osterix-GFP-Cre mice.
(E) BMD, BV/TV, Tb.Th, Tb.N, and Tb.Sp were
determined by microcomputed tomography in 12-
week-old Mmp14f/f and Mmp14f/f/Osterix-GFP-
Cre mice (n = 10). Data are presented as mean ±
SEM. *p < 0.05, **p < 0.01, unpaired t test.
(F) Histology of femur from 12-week-old Mmp14f/f
and Mmp14f/f/Osterix-GFP-Cre mice. The scale
bar represents 1 mm.
(G) Relative mRNA expression of adipogenic
markers in bone-marrow RNA extracts from 12-
week-old Mmp14f/f and Mmp14f/f/Osterix-GFP-
Cre mice (n = 6). Data are presented as mean ±
SEM. Not significant, unpaired t test.
See also Figure S2.
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regulated in MT1-MMP null SSCs cultured in 3D collagen gels,
despite comparable levels of total FAK (T-FAK) or b1-integrin
(Figure 4F). Similarly, in Mmp14f/f mice, active b1-integrin is
readily detected in osteoblast-related cells surrounding bone
as well as in mesenchymal progenitor/SSCs (Figure 4G). How-
ever, although the total number of Osterix-positive cells is
decreased in the calvaria of Mmp14f/f/Dermo1-Cre mice, active
b1-integrin staining is even more dramatically reduced in tan-
dem, with an almost complete loss of P-FAK in calvarial extracts
(Figures 4G and 4H).
Highlighting a dominant role for b1-integrin signaling in regu-
lating SSC differentiation in 3D culture, when b1-integrin activity
is blocked with neutralizing antibodies, the osteogenic potential
of WT SSCs is inhibited, whereas adipogenesis and chondro-
genesis are enhanced (Figures S4B and S4C). Given these re-
sults, we sought to determine whether integrin activation alone406 Developmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Inc.could bypass the 3D-specific require-
ment for MT1-MMP in the SSC differenti-
ation program. As such, MT1-MMP/
SSCs were transduced with either WT
b1-integrin or a series of activated b1-in-
tegrin mutants, and the cells were
cultured in 3D collagen. Importantly,
expression of either a constitutively activeb1-integrin mutant (G429N) or a V737N b1-integrin mutant that
supports integrin clustering (Paszek et al., 2005), but not the
WT integrin, successfully triggers FAK activation in MT1-
MMP/SSCswhile rescuing osteogenic potential and inhibiting
adipogenic activity (Figures 4I–4K); although both b1-integrin
mutants are able to rescue the MT1-MMP null phenotype, the
V737N self-clustering variant is more active. Hence, the forced
activation of b1-integrin in MT1-MMP/ SSCs bypasses the
3D-specific defects observed in lineage commitment and
differentiation.
Consistent with the unimpaired ability of MT1-MMP/ SSCs
to commit to the osteoblast and adipocyte lineages in 2D culture
(Figures S3A and S3B), MT1-MMP null SSCs activate b1-integrin
and FAK in a fashion indistinguishable from that observed in
MT1-MMP+/+ SSCs under planar culture conditions (Figures
S4D and S4E). Although these results rule out any requirement
for MT1-MMP-dependent proteolysis of cell-associated or
Figure 3. MT1-MMP Regulates SSC
Commitment and Differentiation
(A) Bone-marrow-derived SSCs were isolated
fromMmp14+/+ andMmp14/ mice and cultured
under osteogenic conditions for 7 days (alkaline
phosphatase stained) or 14 days (alizarin red S
stained) in 3D collagen, under adipogenic condi-
tions in 3D collagen for 7 days (oil red O stained), or
under chondrogenic conditions for 21 days
(safranin O/fast green stained). The scale bars
represent 100 mm.
(B) Relative mRNA expression of osteogenic, adi-
pogenic, and chondrogenic markers from the
cultures shown in (A) (n = 3). Data are presented as
mean ± SEM. **p < 0.01, unpaired t test.
(C) Schematic of the overall experimental design
for in vivo implantation.
(D) Histology of tissues isolated from mice trans-
planted with Mmp14+/+ or Mmp14/ SSCs. The
scale bars represent 100 mm (n = 5).
(E) Experimental design of chondrogenesis in vivo.
(F) Safranin O staining and chondrogenic marker
expression levels of cartilage-like tissues isolated
from mice transplanted with Mmp14+/+ or
Mmp14/ SSCs cultured as described in (E). The
scale bar represents 100 mm (n = 5). Data are
presented as mean ± SEM. **p < 0.01, unpaired
t test.
See also Figure S3.
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MT1-MMP-derived proteolytic products conceivably control
stem cell fate, but only in 3D culture. As such, MT1-MMP+/+Developmental Cell 25, 402–andMT1-MMP/ SSCs were embedded
in 3D collagen gels and cocultured
together in a dual osteogenic and adipo-
genic induction medium (Figure 5A). Un-
der these conditions, however, WT cells
are unable to rescue the MT1-MMP null
phenotype (Figure 5B). Alternatively, if
MT1-MMP activity is restricted to the
control of 3D cell shape, then MT1-
MMP+/+ SSCs should recapitulate the
MT1-MMP null phenotype if embedded
in matrices whose structure is resistant
to MT1-MMP-dependent hydrolysis.
Hence, WT SSCs were cultured in syn-
thetic poly(ethylene glycol) hydrogels
that incorporate MT1-MMP-sensitive or
-insensitive peptide cross-bridges (Ehr-
bar et al., 2011) (Figure 5C). As expected,
whereas MT1-MMP+/+ SSCs are able to
alter cell shape and activate b1-integrin
as well as FAK inMT1-MMP-hydrolyzable
hydrogels, the WT cells remain ‘‘locked’’
in a spherical shape in the MT1-MMP-
resistant matrix, and the integrin/FAK
axis is not engaged (Figures 5D–5F).
Further, when WT SSCs are cultured in
MT1-MMP-sensitive hydrogels in the
combined presence of osteogenic andadipogenic factors, the cells preferentially commit to osteoblas-
togenesis (Figures 5G and 5H). Conversely, in MT1-MMP-resis-
tant hydrogels, WT SSCs that are prevented from undergoing416, May 28, 2013 ª2013 Elsevier Inc. 407
Figure 4. MT1-MMP-Dependent ECM Remodeling Regulates SSC Commitment by Activating b1-Integrin Signaling
(A) MT1-MMP/ SSCs were transduced with lentivirus expressing HA-taggedWTMT1-MMP (WTMT1), anMT1-MMPmutant (MT1E/A), or an empty vector (EV).
Collagen degradation results are shown in the left-hand panel (collagen colored red). The scale bar represents 200 mm. The expression of the HA-tagged
MT1-MMP proteins is shown in the right-hand panel.
(B) ALP and oil red O staining of SSCs from (A) cultured under osteogenic conditions in 3D collagen for 14 days or following safranin O staining of SSCs cultured
under micromass chondrogenic conditions for 21 days. Relative mRNA expression of markers is shown in the right-hand panels (n = 3). The scale bars represent
100 mm. Data are presented as mean ± SEM. **p < 0.01, one-way ANOVA.
(C) Collagen cleavage in newborn (1-day-old) calvarial bone and suture. The scale bar represents 50 mm. In the lower panels, collagen deposition in newborn
calvarial bone and suture is shown as detected by confocal imaging of SHG signals (forward scattering, red; backward scattering, blue). The scale bar represents
50 mm.
(legend continued on next page)
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MT1-MMP Regulates SSC Lineage Commitmentshape change alternatively commit to adipogenesis (Figures 5G
and 5H). In alginate gels, an MMP-insensitive, polysaccharide
matrix, MT1-MMP+/+ or MT1-MMP/ SSCs costimulated
with osteogenic and adipogenic factors, or chondrogenic
factors alone, retain spherical shapes and display equivalent
osteogenic, adipogenic, and chondrogenic potential (Fig-
ure S5). Taken together, these results support a model wherein
MT1-MMP-dependent proteolysis of the pericellular ECM
drives the cell-shape changes necessary for b1-integrin
activation.
ECM Remodeling and the RhoGTPase/ROCK-
Dependent Control of Pericellular Rigidity
In 2D culture, cell-shape changes associated with b1-integrin
activation trigger RhoGTPase-dependent cytoskeletal reorgani-
zation (Eyckmans et al., 2011). Consistent with an MT1-MMP-
dependent requirement for b1-integrin activation in 3D collagen
hydrogels, MT1-MMP/ SSCs express decreased Rho-GTP
levels relative to WT cells (Figure 6A). In vivo—as in 3D cul-
ture—decreased RhoGTPase activity is similarly found in
calvarial extracts isolated from MT1-MMPf/f/Dermo1-Cre mice
relative to MT1-MMPf/f mice (Figure 6A). Furthermore, the 3D-
specific defects in RhoGTPase activation observed in MT1-
MMP null SSCs can be rescued by expressing WT MT1-MMP
but not the catalytically inactive protease (Figure 6B). A direct
link between b1-integrin activation and the induction of Rho-
GTPase activity is confirmed by culturing MT1-MMP+/+ SSCs
in 3D collagen gels in the presence of neutralizing anti-b1-
integrin antibody wherein RhoGTPase activation is inhibited (Fig-
ure 6C). Conversely, defects in RhoGTPase activation as well
as F-actin organization observed in MT1-MMP/ SSCs in 3D
culture are rescued fully by expressing either the G429N or
V737N b1-integrin mutants in the null cells without affecting
cell morphology or size (Figures S6A–S6D).
RhoGTPase-dependent ROCK activation upregulates cyto-
skeletal tension by triggering the assembly of actomyosin
networks (Eyckmans et al., 2011). To determine whether MT1-
MMP controls the magnitude of the traction forces exerted by
SSCs in collagen gels, fibril stiffness in 3D cultures was assessed
by laser tweezer-based active microrheology (Kotlarchyk et al.,
2011) (Figure 6D). Whereas MT1-MMP+/+ SSCs exert traction
on the surrounding 3D collagen matrix that increases pericellular
rigidity to levels 4-fold greater than baseline, MMP14/ SSCs
display a complete defect in their ability to increase local rigidity
(Figure 6E; Figure S6E). The critical importance of these trac-(D) Three-dimensional reconstruction and relative cell-surface area of SSCs isolate
Data are presented as mean ± SEM. **p < 0.01, unpaired t test.
(E) Immunofluorescence of total (green) and active (red) b1-integrin in SSCs isolate
represents 15 mm.
(F) Western blot of P-FAK, T-FAK, and total b1-integrin in SSCs isolated from Mm
(G) Immunofluorescence of total and active b1-integrin in newborn calvarial cells
(H) Western blot of P-FAK and T-FAK in calvarial lysates isolated from newborn
(I) MT1-MMP/ SSCs transduced with an empty vector lentivirus or viruses ex
cultured in 3D collagen gels for 2 days and probed with anti-b1-integrin, P-FAK,
(J) Relative mRNA expression of osteogenic markers in the lentiviral-transduced c
3). Data are presented as mean ± SEM. **p < 0.01, one-way ANOVA.
(K) Relative mRNA expression of adipogenic markers in SSCs shown in (I) cultu
presented as mean ± SEM. **p < 0.01, one-way ANOVA.
See also Figure S4.
Devetional forces on the SSC differentiation program is confirmed
by the ability of the ROCK inhibitor Y27632 to reduce cytoskel-
etal tension in MT1-MMP+/+ SSCs (Figure S6F), and recapitulate
the phenotype of MT1-MMP/ SSCs, namely an inability to fully
commit to osteogenesis while promoting adipogenesis as well
as chondrogenesis in 3D culture (Figures 6F and 6G). Thus,
MT1-MMP-dependent remodeling of the ECM triggers b1-integ-
rin signaling and RhoGTPase activation, leading to the ROCK-
mediated increases in pericellular rigidity that control SSC
commitment.
MT1-MMP-Mediated ECM Remodeling Triggers YAP/
TAZ-Dependent SSC Commitment
Recent studies link ROCK, stress fiber assembly, and cytoskel-
etal force generation to the activation of YAP and TAZ nuclear
signaling networks (Dupont et al., 2011; Sansores-Garcia et al.,
2011; Wada et al., 2011). As such, we sought to determine
whether YAP/TAZ expression and intracellular localization in
SSCs are regulated by MT1-MMP in a 3D-specific fashion. Pre-
liminary studies performed in 3D collagen gels demonstrate that
(1) inhibiting either RhoGTPase or ROCK with C3 toxin or
Y27632, respectively, or (2) blocking F-actin assembly with la-
trunculin A or cytochalasin D decreases the expression and nu-
clear localization of YAP/TAZ (Figures 7A and 7B). Given that
YAP/TAZ protein levels and nuclear localization are regulated
by Rho/ROCK activity, and the 3D-specific ability of MT1-MMP
to trigger Rho/ROCK signaling, the status of the transcriptional
coactivators was examined in WT and MT1-MMP/ SSCs.
Relative to WT SSCs, 3D-embedded, MT1-MMP/ SSCs ex-
press only low levels of YAP/TAZ protein, with the bulk of their
content confined to the cytosolic compartment (Figures 7C–
7E). Interestingly, MT1-MMP/ SSCs express YAP and TAZ
mRNAs at WT levels (Figure S7A), but preferentially accumulate
phosphorylated forms of YAP that are normally sequestered in
the cytosol and/or targeted for proteosomal degradation (similar
increases in phospho-YAP are found when WT SSCs are
cultured in the presence of C3 toxin or Y27632) (Figure S7B)
(Zhao et al., 2012). Consistent with the ability of constitutively
active b1-integrins to rescue RhoGTPase activation and F-actin
assembly in MT1-MMP/ SSCs, transducing these cells with
the b1-integrin mutant expression vectors also increases YAP/
TAZ levels and directs their localization to the nuclear compart-
ment (Figures 7F–7H). By contrast, in 2D culture, where MT1-
MMP does not play a required role in directing cell-shape
changes, YAP/TAZ protein expression, phosphorylation, andd fromMmp14+/+/EGFP orMmp14//EGFPmice and cultured in 3D collagen.
d fromMmp14+/+ orMmp14/mice and cultured in 3D collagen. The scale bar
p14+/+ or Mmp14/ mice and cultured in 3D collagen for 2 days.
of Mmp14f/f or Mmp14f/f/Dermo1-Cre mice. The scale bar represents 50 mm.
Mmp14f/f or Mmp14f/f/Dermo1-Cre mice.
pressing either the human WT or mutant b1-integrins (G429N or V737N) were
and T-FAK antibodies.
ells from (I) cultured in 3D collagen for 7 days under osteogenic conditions (n =
red under adipogenic conditions in 3D collagen for 7 days (n = 3). Data are
lopmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Inc. 409
Figure 5. b1-Integrin Activation and Three-
Dimensional Cell-Shape Change
(A) Schematic of MT1-MMP+/+ and MT1-MMP/
SSCs in 3D collagen coculture for 7 days under
dual osteogenic/adipogenic induction.
(B) Osteogenic and adipogenic markers quantified
by real-time PCR in MT1-MMP+/+ and MT1-
MMP/ SSCs cocultured as described in (A) (n =
3). Data are presented as mean ± SEM. **p < 0.01,
unpaired t test.
(C) Schematic of PEG-based hydrogel. MT1-
MMP-sensitive or -insensitive peptides were
crosslinked to the PEG backbone with a cell-ad-
hesive RGD peptide integrated into the hydrogel.
(D) Phalloidin staining of MT1-MMP wild-type
SSCs cultured in MT1-MMP-degradable or
-nondegradable hydrogels for 15 days. The scale
bar represents 10 mm.
(E) Immunofluorescence of active b1-integrin in
SSCs cultured in 3D PEG-based hydrogel for
15 days. The scale bar represents 15 mm.
(F) Western blot of P-FAK and T-FAK in SSCs
cultured in 3D PEG-based hydrogel for 15 days.
(G) Relative mRNA expression of osteogenic
markers in MT1-MMP+/+ SSCs cultured in 3D
hydrogels (MMP-degradable or -nondegradable)
for 15 days followed by a 7 day period under dual
osteogenic/adipogenic induction (n = 3). Data are
presented as mean ± SEM. **p < 0.01, unpaired
t test.
(H) Relative mRNA expression of adipogenic
markers in MT1-MMP+/+ SSCs cultured in 3D
hydrogels (MMP-degradable or -nondegradable)
for 15 days followed by a 7 day period under dual
induction conditions (n = 3). Data are presented as
mean ± SEM. **p < 0.01, unpaired t test.
See also Figure S5.
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MT1-MMP Regulates SSC Lineage Commitmentnuclear localization are regulated comparably in MT1-MMP/
and MT1-MMP-transduced null cells (Figures S7C–S7E).
Finally, to determine whether YAP/TAZ expression/nuclear
localization is sufficient to control SSC commitment in 3D culture
independently of MT1-MMP activity, MT1-MMP/ SSCs were
transduced with constitutively active forms of YAP (i.e., 5SA-
YAP) or TAZ (TAZ-S89A) and differentiation was induced
(Dupont et al., 2011; Hong et al., 2005). Remarkably, following
5SA-YAP or TAZ-S89A transduction, 3D-specific lineage
commitment defects in MT1-MMP-deleted SSCs are rescued
with marked increases in osteogenesis, complementing de-
creases in adipogenesis and chondrogenesis to WT levels
without affecting SSC morphology (Figures 7I–7L; Figures S7F–
S7I). Given the dominant role of the YAP/TAZ axis in regulating
SSC differentiation in vitro, the status of the transcriptional acti-410 Developmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Inc.vators was next assessed in vivo. As pre-
dicted, whereas calvaria from Mmp14f/f
mice display high expression levels of
the YAP/TAZ proteins coupled with
strong nuclear staining, extracts pre-
pared from Mmp14f/f/Dermo1-Cre mice
exhibit a striking decrease in YAP and
TAZby bothwestern blot and immunohis-
tochemistry (Figures 7M and 7N). Impor-tantly, the defective osteogenic potential of MT1-MMP/
SSCs can likewise be rescued in vivo following transduction
either with 5SA-YAP or TAZ-S89A and subcutaneous transplan-
tation into nude mice recipients (Figure 7O). Taken together,
these data identify MT1-MMP as a 3D-specific in vivo regulator
of the YAP/TAZ axis responsible for controlling SSC commitment
and differentiation.
DISCUSSION
Herein, we demonstrate that MT1-MMP directs SSC lineage
commitment and differentiation by controlling a 3D-specific
ECM remodeling program that triggers b1-integrin activation
by modulating cell-shape changes and initiating a downstream
RhoGTPase-actomyosin signaling cascade that drives the
Figure 6. ECM Remodeling Regulates RhoGTPase Signaling, Pericellular Rigidity, and SSC Commitment
(A) Active and total RhoGTPase levels were determined in SSCs isolated fromMmp14+/+ orMmp14/ mice and cultured in 3D collagen for 2 days as well as in
newborn calvarial lysates isolated from Mmp14f/f or Mmp14f/f/Dermo1-Cre mice. Data are presented as mean ± SEM. **p < 0.01, unpaired t test.
(B) Active and total RhoGTPase levels were determined in SSCs isolated from Mmp14/ mice that were transduced with empty vector or lentiviral constructs
expressing WT MT1-MMP (WTMT1) or mutant MT1-MMP (MT1E/A) and cultured in 3D collagen for 2 days. Data are presented as mean ± SEM. **p < 0.01, one-
way ANOVA.
(C) Active and total RhoGTPase levels in SSCs isolated fromMmp14+/+mice and cultured in 3D collagen with rat IgG or anti-b1-integrin antibody for 2 days. Data
are presented as mean ± SEM. **p < 0.01, unpaired t test.
(D) Schematic of local collagen rigidity assayed bymicrorheology. Beads are trapped and oscillated in a laser trap where bead position is detected by a quadrant
photodiode. The interaction between the elastic force from the matrix and the optical force from the laser is used to determine the elastic modulus (G0).
(E) G0 values near (<5 mm) and distant (>100 mm) fromMT1-MMP+/+ andMT1-MMP/SSCs cultured in 3D collagen are shown. Each point represents the average
G0 (across frequencies) for each bead. Data are presented as mean ± SEM. **p < 0.01, one-way ANOVA.
(F) Relative mRNA expression of osteogenic and adipogenic markers in MT1-MMP+/+ SSCs cultured in 3D collagen and treated with or without 10 mMY27632 for
7 days under osteogenic or adipogenic conditions, respectively (n = 3). Data are presented as mean ± SEM. **p < 0.01, unpaired t test.
(legend continued on next page)
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MT1-MMP Regulates SSC Lineage Commitmentnuclear localization of the YAP/TAZ cotranscriptional activators
(Figure 7P). Both in vitro and in vivo, MT1-MMP-deleted SSCs
display profound defects in osteogenesis that are coupled with
compensatory increases in adipogenic and chondrogenic
potentials. Earlier studies proposed that the loss of MT1-MMP
proteolytic activity in terminally differentiated osteoblasts or
chondrocytes affects skeletal development directly as a function
of impaired collagen remodeling or FGFR2 signaling (Chan et al.,
2012; Holmbeck et al., 1999, 2003; Zhou et al., 2000). However,
our studies describe a more upstream impact on the overall SSC
lineage commitment program itself. Although Dermo1-Cre
expression extends beyond SSCs to include a number of
mesenchymal tissues (Tran et al., 2010), each of the phenotypic
defects we observed in osteoblastogenesis, chondrogenesis,
and adipogenesis in the targeted mice is duplicated by MT1-
MMP/ SSCs cultured in vitro as well as following their in vivo
transplantation into WT recipients. Furthermore, when MT1-
MMP is alternatively targeted in committed osteoblasts/osteo-
cytes using Osterix-Cre transgenic mice, skeletal defects are
confined to the osteoblast lineage alone. Although Osterix-Cre
can also be expressed in (pre)hypertrophic chondrocytes
(Zhou et al., 2010), cartilage remodeling is unaffected in these
mice—a finding consistent with our inability to detect MT1-
MMP expression in cartilaginous tissues and the inability of
MT1-MMP knockout transgenicmice engineered to overexpress
MT1-MMP in chondrocytes to resorb the expanded cartilage
network (Szabova et al., 2009).
In considering the potential mechanisms by which MT1-MMP
regulates SSC function, the expanse of the enzyme’s substrate
repertoire—from ECM macromolecules and cell-surface mole-
cules to chemokines and growth factors (Jin et al., 2011; Nishida
et al., 2012; Rowe and Weiss, 2009)—raised a number of possi-
bilities. However, in contradistinction to their in vivo phenotype,
MT1-MMP null SSCs cultured in vitro under standard, 2D con-
ditions maintain a completely normal potential for lineage
commitment and differentiation. Hence, MT1-MMP-dependent
hydrolysis of intracellular, cell-surface, or secreted macromole-
cules does not play an obligatory role in controlling SSC lineage
decisions. By contrast, only when SSCs are embedded in 3D
type I collagen hydrogels designed to recapitulate an in vivo-
likemicroenvironment do theMT1-MMP-deleted cells display al-
terations in lineage commitment similar to those observed in
MT1-MMP-targeted mice in vivo. Although 3D type I collagen
matrices do not necessarily reflect all in vivo environments, we
note that SSCs express multiple collagen-binding integrins as
well as type I collagen (Popov et al., 2011; Rodrı´guez et al.,
2000). Further, SSCs are found either embedded within—or re-
cruited to—type I collagen-rich tissues in vivo (Maes et al.,
2010; Morikawa et al., 2009; Nilsson et al., 1998; Tancred
et al., 2009; Tang et al., 2009). Nevertheless, MT1-MMP-ECM in-
teractions are not limited to type I collagen alone, and SSCs can
also be found within type II/III collagen-rich as well as fibro-
nectin-replete tissues that are also sensitive to MT1-MMP-
dependent hydrolysis (Sabeh et al., 2010; Shi and Sottile,(G) Alcian blue staining of MT1-MMP+/+ SSCs cultured in 3D collagen and treated
scale bar represents 100 mm. Relative mRNA expression of chondrogenic marker
**p < 0.01, unpaired t test.
See also Figure S6.
412 Developmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier In2011). Last, although MT1-MMP can activate downstream
MMPs (i.e., MMP-2, MMP-8, or MMP-13), mice harboring global
knockouts of these proteinases display only subtle and transient
defects in skeletal development relative to those described here-
in (Krane and Inada, 2008).
Insights gleaned from 2D and 3D culture systems have led to
the construction of molecular models whereby cell-shape-
dependent integrin-ligand engagement elicits a signaling
cascade that induces Rho/ROCK activation, stress fiber forma-
tion, focal adhesion site maturation, and increased cytoskeletal
tension (Eyckmans et al., 2011). AlthoughMT1-MMP-dependent
cell-shape changes cannot be decoupled from MT1-MMP-
catalyzed increases in pericellular ECM rigidity, each of these
variables is known to play critical roles in SSC commitment pro-
grams (Eyckmans et al., 2011; Tee et al., 2011). Conversely, in
the absence of MT1-MMP—or under conditions in which MT1-
MMP is downregulated (e.g., during adipogenesis or chondro-
genesis)—SSCs confine themselves to a smaller surface area/
volume, decrease integrin activation as well as Rho-linked
signaling cascades, and alternatively commit to adipogenic or
chondrogenic pathways. It is important to stress that MT1-
MMP null SSCs can be redirected away from adipogenesis or
chondrogenesis toward osteogenesis in 3D culture by express-
ing b1-integrin mutants that trigger downstream signaling
cascades independently of any requirement for pericellular col-
lagenolysis. Nevertheless, despite the ability of forced b1-integ-
rin signaling to circumvent the requirement for MT1-MMP
in vitro, the proteinase appears to play a required role in directing
SSC commitment in vivo and, in its absence, alternate mecha-
nisms for bypassing ECM remodeling are unable to optimally
control SSC commitment.
In probing for final effector pathways capable of transducing
MT1-MMP-initiated signaling cascades into SSC lineage
commitment decisions, earlier studies identified the transcrip-
tional coactivator TAZ as a key regulator of SSC-osteoblast dif-
ferentiation under 2D culture conditions (Hong et al., 2005).
TAZ, by virtue of its ability to interact with RNX2 and PPARg, di-
rects transcriptional enhancement ofRNX2activity, thereby stim-
ulating osteoblastogenesis, whereas repressing PPARg func-
tions critical to adipocyte formation (Hong et al., 2005).
Conversely, in the absence of TAZ, SSC commitment to osteo-
blast formation is prevented whereas promoting adipogenesis
(Hong et al., 2005). More recently, the cotranscriptional activities
of TAZaswell asYAPhavebeenshown to fall under the regulation
of F-actin assembly, which in turn serves to promote YAP/TAZ
protein stability andnuclear localization (Dupont et al., 2011; San-
sores-Garcia et al., 2011; Wada et al., 2011; Zhao et al., 2012).
Currently, requirements for ROCK-mediated, F-actin-dependent
cytoskeleton tension or regulation of the upstream Hippo path-
way, particularly the Lats1/2 kinases, in the YAP/TAZ activation
network remain controversial (Zhao et al., 2012). Nevertheless,
efforts to dissect the functional impact of YAP/TAZ on cell
behavior or differentiation in mammalian models have been
confined to 2D culture systems where requirements for ECMwith or without 10 mMY27632 for 21 days under chondrogenic conditions. The
s is shown in the right-hand panel (n = 3). Data are presented as mean ± SEM.
c.
Figure 7. MT1-MMP-Dependent YAP/TAZ Activation Triggers SSC Commitment
(A) YAP and TAZ expression levels in MT1-MMP+/+ SSCs embedded in 3D collagen gels for 2 days and treated with Rho inhibitor C3 (3 mg/ml), ROCK inhibitor
Y27632 (10 mM), latrunculin A (Lat A; 0.5 mM), or cytochalasin D (CytoD; 1 mM).
(B) Quantification of nuclear-stained cells from (A) (n = 3). Data are presented as mean ± SEM. **p < 0.01, one-way ANOVA.
(C) YAP and TAZ expression levels in MT1-MMP+/+ or MT1-MMP/ SSCs embedded in 3D collagen gels for 2 days.
(D) YAP and TAZ localization in MT1-MMP+/+ or MT1-MMP/ SSCs embedded in 3D collagen gels for 2 days. The scale bar represents 20 mm.
(E) Quantification of nuclear-stained cells from (D) (n = 3). Data are presented as mean ± SEM. **p < 0.01, unpaired t test.
(F) YAP and TAZ expression levels in MT1-MMP/ SSCs infected with an empty vector or lentiviral constructs expressing G429N or V737N b1-integrin mutants
and cultured in 3D collagen for 2 days.
(G) YAP and TAZ localization in cells from (F) embedded in 3D collagen gels for 2 days. The scale bar represents 20 mm.
(H) Quantification of nuclear-stained cells from (G) (n = 3). Data are presented as mean ± SEM. **p < 0.01, one-way ANOVA.
(I) Expression of YAP-5SA probed with an anti-Flag antibody in MT1-MMP/ SSCs infected with a lentiviral empty vector or virus expressing Flag-tagged
YAP-5SA.
(legend continued on next page)
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MT1-MMP Regulates SSC Lineage Commitmentremodeling havebeenbypassed.Alternatively, using the3DECM
as a more physiologic template for developing insights into cell
behavior in the in vivo setting, we now identify MT1-MMP as an
upstream and necessary activating cofactor in regulating the
YAP/TAZ-dependent control of SSC lineage commitment.
In the bone-marrow niche and bone matrix in vivo, SSCs
display pericyte-like characteristics where they reside in juxta-
position to endothelial cells, osteoblasts, macrophages, and he-
matopoietic stem cells (Me´ndez-Ferrer et al., 2010; Morikawa
et al., 2009; Omatsu et al., 2010; Park et al., 2012; Sacchetti
et al., 2007). Whereas our studies have focused on SSC-fate de-
cisions limited to the selection of osteoblastogenic, adipogenic,
or chondrogenic differentiation programs, recent studies have
identified additional roles for bone-marrow SSCs, adipocytes,
and osteoblasts in controlling bone repair, hematopoiesis,
lymphocyte commitment, and differentiation as well as blood
cell mobilization (Maes et al., 2010; Naveiras et al., 2009; Park
et al., 2012; Raaijmakers et al., 2010; Shi et al., 2011; Zhu
et al., 2007). These complex intercellular interactions are further
complemented by new roles for MT1-MMP in controlling macro-
phage gene expression by proteinase-dependent as well as
-independent mechanisms (Ehninger and Trumpp, 2011; Saka-
moto and Seiki, 2010; Shimizu-Hirota et al., 2012). Together,
these findings support a model wherein MT1-MMP—a protein-
asewhose expression in humans is potentially regulated by poly-
morphisms, mutations, and diverse skeletal-associated factors
ranging from estrogens to fluid sheer stress (Chun et al., 2010;
Evans et al., 2012; Kang et al., 2011; Liao et al., 2004)—serves
as a key regulator of the SSC niche.
EXPERIMENTAL PROCEDURES
Mice
To generate the Mmp14Lox strain, a targeted ES cell line (Figure 1G) was
injected into 129SV blastocysts with chimeric offspring mated to generate
the Mmp14Lox/ allele. Mmp14Lox/ mice were mated to C57BL/6 mice for at
least six generations, and Mmp14Lox/ mice were then bred to generate
Mmp14Lox/Lox mice. MT1-MMP+/LacZ mice in a C57BL/6 background were
generated as described (Yana et al., 2007). Dermo1-Cre knockin mice (Yu
et al., 2003), Osterix-GFP-Cre transgenic mice (Rodda and McMahon, 2006),
and CByJ.B6-Tg (CAG-EGFP)1Osb/J mice were obtained from the Jackson
Laboratory.Mmp14+/mice (Swiss Black background), obtained from the Na-
tional Institutes of Health (Holmbeck et al., 1999), were mated to produce
Mmp14/ and Mmp14+/+ mice. Nu/Nu mice were bought from Charles River
Laboratories. All mouse work was performed with the approval of the Institu-
tional Animal Care and Use Committee of the University of Michigan.
Cell Culture
Bone-marrow cells were isolated from mice and cultured in DMEM supple-
mented with 10% fetal bovine serum (FBS). The adherent colonies were(J) Osteogenic marker expression in MT1-MMP/ SSCs infected with a lentivir
collagen, and cultured for 7 days under osteogenic conditions (n = 3). Data are p
(K) Adipogenic marker expression in MT1-MMP/ SSCs infected with a lentivir
collagen, and cultured for 7 days under adipogenic conditions (n = 3). Data are p
(L) Chondrogenic marker expression in MT1-MMP/ SSCs infected with a lentivir
collagen for 14 days under chondrogenic conditions (n = 3). Data are presented
(M) YAP and TAZ localization in newborn calvaria of Mmp14f/f or Mmp14f/f/Derm
(N) YAP and TAZ protein levels in newborn Mmp14f/f or Mmp14f/f/Dermo1-Cre c
(O) Histology of tissue isolated from mice transplanted with MT1-MMP/ SSCs
tagged YAP-5SA or TAZ-S89A (n = 5). The scale bar represents 100 mm.
(P) Schematic model of MT1-MMP-dependent control of SSC lineage commitme
See also Figure S7.
414 Developmental Cell 25, 402–416, May 28, 2013 ª2013 Elsevier Insorted by flow cytometry with antibodies to Sca-1, CD29, CD45, and
CD11b as described (Tang et al., 2009). The sorted cells (termed SSCs)
were cultured and used within five passages (Tang et al., 2009). For 3D cul-
ture, 5 3 105 cells/ml were embedded in 2.16 mg/ml rat-tail-derived type I
collagen gels (Sabeh et al., 2009) and cultured in Transwell dishes with a
0.4 mm pore size. For PEG-based hydrogel cultures, 2 3 105 cells/ml were
mixed with hydrogel solution and cultured according to the manufacturer’s
instructions (QGel SA). RGD peptide-modified alginate gels were prepared
as described (Yu et al., 2009). In brief, 2 3 105 cells/ml (for osteogenesis
and adipogenesis) or 2 3 106 cells/ml (for chondrogenesis) were suspended
in the peptide-modified alginate gel solution and a CaCl2 solution was added
to induce solidification. For 2D culture, SSCs were cultured at low density
atop tissue-culture plastic or glass slides in six-well dishes (1 3 104 cells/
9.4 cm2).Differentiation of SSCs In Vitro
SSCs were induced with osteogenic medium (50 mM ascorbic acid, 10 nM
dexamethasone, 10 mM b-glycerolphosphate, and 2% FBS in low-glucose
DMEM) or adipogenic medium (1 mM dexamethasone, 50 mM indomethacin,
500 nM 3-isobutyl-1-methylxanthine, 5 mg/ml insulin, and 2% FBS in low-
glucose DMEM) (Anjos-Afonso and Bonnet, 2008). For dual induction, equal
volumes of osteogenic and adipogenic media were added to the SSC cultures
(McBeath et al., 2004). For chondrogenesis, SSC micromass cultures were
carried out as described (Murdoch et al., 2007) or with cells embedded in
either 3D collagen or alginate. SSCs were induced with a StemPro Chondro-
genesis Differentiation Kit (Invitrogen). The differentiated cells were stained for
alkaline phosphatase activity, alizarin red S for detecting calcium deposits, oil
red O for detecting lipid deposits, or Alcian blue (glycosaminoglycans) and
safranin O (cartilage mucopolysaccharides)/fast green for monitoring
chondrogenesis.Vector Construction and Gene Expression
Where indicated, MT1-MMP/ SSCs were transduced with either full-length
human MT1-MMP, a catalytically inactive MT1-MMP mutant harboring an
E-A240 substitution in the catalytic domain (Shimizu-Hirota et al., 2012), a
constitutively active b1-integrin mutant (G429N), a b1-integrin clustering
mutant (V737N) (Paszek et al., 2005), constitutively active 5SA-YAP1 (Zhao
et al., 2012), or constitutively active TAZ-S89A (Hong et al., 2005). All con-
structs were cloned into the pLentilox-IRS-GFP lentiviral vector, and trans-
duced SSCswere sorted by flow cytometry. Expression of exogenous proteins
was confirmed by western blot.Statistics
Statistical analysis was performed with the Student’s t test or by two-way
ANOVA. *p < 0.05, **p < 0.01. All experiments were repeated three or more
times.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2013.04.011.al control vector or virus expressing Flag-tagged YAP-5SA, embedded in 3D
resented as mean ± SEM. **p < 0.01, unpaired t test.
al control vector or virus expressing Flag-tagged YAP-5SA, embedded in 3D
resented as mean ± SEM. **p < 0.01, unpaired t test.
al control vector or a virus expressing Flag-tagged YAP-5SA and cultured in 3D
as mean ± SEM. *p < 0.05, **p < 0.01, unpaired t test.
o1-Cre mice. The scale bar represents 50 mm.
alvarial lysates.
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